C-Rad AB (OSTO:CRAD B) Total Receivables : kr236.6 Mil (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is C-Rad AB Total Receivables?

C-Rad AB's Total Receivables for the quarter that ended in Dec. 2024 was kr236.6 Mil.

C-Rad AB Total Receivables Historical Data

The historical data trend for C-Rad AB's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Rad AB Total Receivables Chart

C-Rad AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Receivables

Get a 7-Day Free Trial

79.17

119.45

139.02

164.59

236.60

C-Rad AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Receivables	Get a 7-Day Free Trial															164.59	185.40	225.20	223.60	236.60

C-Rad AB Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

C-Rad AB Total Receivables Related Terms

Thank you for viewing the detailed overview of C-Rad AB's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

C-Rad AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (OSTO:CRAD B) » Definitions » Total Receivables

Comparable Companies

Traded in Other Exchanges

0R44:UK 24C:Germany

Address

Sjukhusvagen 12K, Uppsala, SWE, 753 09

Website

https://www.c-rad.com

C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa and the rest from Americas and Asia Pacific region.

C-Rad AB Headlines

No Headlines